Evidence map›Paper›PMID 42499507›Full record

ArticleFrontiers in pharmacology2026

Editorial: The evolution in pharmacology of infectious diseases: 2025.

Exequiel O J Porta, Ali Saffaei, Karunakaran Kalesh, Katrien Van Bocxlaer

Abstract readEditorial
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Exequiel O J Porta *UCL School of Pharmacy, University College London, London, United Kingdom.
Ali Saffaei *Department of Pharmaceutical Care, Sepid Nikan Hospital, Tehran, Iran.
Karunakaran Kalesh *School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom.
Katrien Van Bocxlaer *Skin Research Centre, Hull York Medical School, York Biomedical Research Institute, University of York, York, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistancedrug repurposinginfectious disease pharmacologyneglected tropical diseasesphage therapypharmacokinetics/pharmacodynamicsprecision medicinetherapeutic drug monitoring

Identifiers

PMID42499507
PMCPMC13395742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.